These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 27127124)
21. Cytokine gene polymorphisms in the susceptibility to acute coronary syndrome. Babu BM; Reddy BP; Priya VH; Munshi A; Rani HS; Latha GS; Rao VD; Jyothy A Genet Test Mol Biomarkers; 2012 May; 16(5):359-65. PubMed ID: 22372709 [TBL] [Abstract][Full Text] [Related]
22. Association between -1082G/A, -819C/T, and -592C/A genetic polymorphisms in IL-10 and risk of type 2 diabetes mellitus in a Chinese population. Dong QY; Liu XM; Liang CG; Du WH; Wang YL; Li WX; Gao GQ Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706650 [TBL] [Abstract][Full Text] [Related]
23. Associations of Matrix Metalloproteinase-8 Genotypes to Renal Cell Carcinoma in Taiwan. Liao CH; Chien WC; Chang SY; Lin YH; Wang YC; Huang WC; Mong MC; Yang YC; Wu WT; Chen JC; Chang CH; Tsai CW; Bau DT; Chang WS Anticancer Res; 2024 May; 44(5):1931-1938. PubMed ID: 38677743 [TBL] [Abstract][Full Text] [Related]
25. Association of IL-4 -590 T>C polymorphism and risk of renal cell carcinoma in a Chinese population. Zhu J; Ju X; Yan F; Qin C; Wang M; Ding Q; Zhang Z; Yin C Int J Immunogenet; 2010 Dec; 37(6):459-65. PubMed ID: 20618516 [TBL] [Abstract][Full Text] [Related]
26. Contribution of Inflammatory Cytokine Interleukin-18 Genotypes to Renal Cell Carcinoma. Chang WS; Shen TC; Yeh WL; Yu CC; Lin HY; Wu HC; Tsai CW; Bau DT Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925760 [TBL] [Abstract][Full Text] [Related]
27. Interleukin-4 promoter polymorphisms: a genetic prognostic factor for survival in metastatic renal cell carcinoma. Kleinrath T; Gassner C; Lackner P; Thurnher M; Ramoner R J Clin Oncol; 2007 Mar; 25(7):845-51. PubMed ID: 17327605 [TBL] [Abstract][Full Text] [Related]
28. The effect of interleukin-10 gene promoter polymorphisms on early-onset coronary artery disease. Karaca E; Kayıkçıoğlu M; Onay H; Gündüz C; Ozkınay F Anadolu Kardiyol Derg; 2011 Jun; 11(4):285-9. PubMed ID: 21543297 [TBL] [Abstract][Full Text] [Related]
29. Association of -592C/A, -819C/T and -1082A/G interleukin-10 promoter polymorphisms with idiopathic recurrent spontaneous abortion. Zammiti W; Mtiraoui N; Cochery-Nouvellon E; Mahjoub T; Almawi WY; Gris JC Mol Hum Reprod; 2006 Dec; 12(12):771-6. PubMed ID: 17041236 [TBL] [Abstract][Full Text] [Related]
30. TNF-α, TNF-β and IL-10 gene polymorphism and association with oral lichen planus risk in Saudi patients. Al-Mohaya MA; Al-Harthi F; Arfin M; Al-Asmari A J Appl Oral Sci; 2015; 23(3):295-301. PubMed ID: 26221924 [TBL] [Abstract][Full Text] [Related]
31. A functional insertion/deletion polymorphism (-94 ins/del ATTG) in the promoter region of the NFKB1 gene is related to the risk of renal cell carcinoma. Cai H; Sun L; Cui L; Cao Q; Qin C; Zhang G; Mao X; Wang M; Zhang Z; Shao P; Yin C Urol Int; 2013; 91(2):206-12. PubMed ID: 23295440 [TBL] [Abstract][Full Text] [Related]
32. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis. de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206 [TBL] [Abstract][Full Text] [Related]
33. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study. Sweeney C; Farrow DC; Schwartz SM; Eaton DL; Checkoway H; Vaughan TL Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):449-54. PubMed ID: 10794492 [TBL] [Abstract][Full Text] [Related]
34. Pro-(IL-18) and Anti-(IL-10) Inflammatory Promoter Genetic Variants (Intrinsic Factors) with Tobacco Exposure (Extrinsic Factors) May Influence Susceptibility and Severity of Prostate Carcinoma: A Prospective Study. Dwivedi S; Singh S; Goel A; Khattri S; Mandhani A; Sharma P; Misra S; Pant KK Asian Pac J Cancer Prev; 2015; 16(8):3173-81. PubMed ID: 25921117 [TBL] [Abstract][Full Text] [Related]
35. The association between interleukin-10 (IL-10) -592C/A, -819T/C, -1082G/A promoter polymorphisms and endometriosis. Malutan AM; Drugan C; Walch K; Drugan T; Ciortea R; Mihu D Arch Gynecol Obstet; 2017 Feb; 295(2):503-510. PubMed ID: 28004192 [TBL] [Abstract][Full Text] [Related]
36. [Polymorphism of interleukin-10 gene promoter and its association with susceptibility to chronic obstructive pulmonary disease in Chinese Han people]. Hu RC; Xu YJ; Zhang ZX; Xie JG Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):504-7. PubMed ID: 14669219 [TBL] [Abstract][Full Text] [Related]
37. Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients. Ezzidi I; Mtiraoui N; Kacem M; Mallat SG; Mohamed MB; Chaieb M; Mahjoub T; Almawi WY Clin Endocrinol (Oxf); 2009 Mar; 70(3):401-7. PubMed ID: 18616700 [TBL] [Abstract][Full Text] [Related]
38. Association of a single-nucleotide polymorphism in the promoter region of the VEGF gene with the risk of renal cell carcinoma. Ajaz S; Khaliq S; Abid A; Hassan AS; Hashmi A; Sultan G; Mohsin R; Mubarrak M; Naqvi SA; Rizvi SA; Mehdi SQ Genet Test Mol Biomarkers; 2011 Sep; 15(9):653-7. PubMed ID: 21491998 [TBL] [Abstract][Full Text] [Related]
39. GNAS1 (Gαs) gene T393C polymorphism and renal cell carcinoma risk in a North Indian population: a case-control study. Arjumand W; Ahmad ST; Nafees S; Ali N; Rashid S; Seth A; Sultana S Genet Test Mol Biomarkers; 2012 Sep; 16(9):1062-6. PubMed ID: 22931242 [TBL] [Abstract][Full Text] [Related]
40. Association between interleukin-10 -1082A/G, -819C/T and -592C/A polymorphisms with deep venous thrombosis. Tang B; Chen YK; Luo WJ; Fu J; Sun JM Hum Immunol; 2014 Mar; 75(3):203-7. PubMed ID: 24374045 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]